Trial intelligence / Profile preview

Pilocarpine as Adjunct to Latanoprost in Glaucoma

NCT02754570Completed

Sponsor
University of Colorado Denver
Start
Jul 2016
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of pilocarpine in Open-angle glaucoma (OAG) and ocular hypertension, sponsored by University of Colorado Denver. Primary endpoint: Change in Intraocular Pressure From Baseline at 4 weeks. Started Jul 2016; status: completed.

02

Drugs

pilocarpine
03

Conditions

Open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT02754570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02754570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call